Health Care & Life Sciences » Biotechnology | Health Discovery Corp.

Health Discovery Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
119.00
1,585.50
1,053.60
1,032.10
44.60
Cost of Goods Sold (COGS) incl. D&A
1,397.90
-
-
-
-
Gross Income
1,279.00
-
-
-
-
SG&A Expense
1,736.00
3,149.90
2,035.00
726.30
581.60
EBIT
3,015.00
1,837.30
1,252.10
38.50
800.70
Unusual Expense
483.70
726.60
338.60
199.90
19.40
Non Operating Income/Expense
-
668.90
815.80
338.10
232.90
Pretax Income
2,524.90
440.70
774.90
176.60
587.10
Consolidated Net Income
2,524.90
440.70
774.90
176.60
587.10
Net Income
2,524.90
440.70
774.90
176.60
587.10
Net Income After Extraordinaries
2,524.90
440.70
774.90
176.60
587.10
Net Income Available to Common
2,669.20
580.20
912.20
112.00
587.10
EPS (Basic)
0.01
0.00
0.00
0.00
0.00
Basic Shares Outstanding
230,268.40
232,374.30
235,494.70
253,292.90
266,052.30
EPS (Diluted)
0.01
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
230,268.40
232,374.30
235,494.70
259,932.90
266,052.30
EBITDA
2,742.60
1,564.40
981.40
305.80
537.00
Non-Operating Interest Income
6.40
1.10
-
-
-
Preferred Dividends
144.20
139.50
137.30
64.60
-

About Health Discovery

View Profile
Address
4243 Dunwoody Club Drive
Atlanta Georgia 30350
United States
Employees -
Website http://www.healthdiscoverycorp.com
Updated 07/08/2019
Health Discovery Corp. is a machine learning company that uses mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the field of molecular diagnostics where such tools are critical to scientific discovery. The firm markets its technology and related developmental expertise to prospects in the healthcare, biotech, and life sciences industries.